Patents by Inventor Jun-Yong Choe

Jun-Yong Choe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Water recognition system, electronic device including the same, and method of recognizing water thereby
    Patent number: 10928343
    Abstract: An electronic device includes a connector connected to a cable external to the electronic device and including a plurality of pins; a first water detection circuit connected to at least one first pin of the plurality of pins and generating a first detection result by detecting whether there is water in the connector based on resistance of the at least one first pin; and a second water detection circuit connected to at least one second pin of the plurality of pins, entering a water detection mode when the first detection result indicates the presence of water, and detecting whether there is water in the connector based on resistance of the at least one second pin.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: February 23, 2021
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Se-jong Park, Hyeon-je Choe, Je-kook Kim, Ji-yong Kim, Tae-jeong Kim, Jun-han Bae, Hyoung-seok Oh, Jong-haeng Lee
  • Human GLUT5 specific inhibitors and methods of treatment
    Patent number: 10822325
    Abstract: The present invention relates to compounds which have been discovered to be potent ligands (inhibitors) of human GLUT5 (glucose transporter type 5), a facilitative glucose transporter that transports fructose, and their use as ligands assays which can uncover additional ligands of GLUT5, having the potential for being used as drugs. In addition, the present invention is directed to compounds, chemical compositions and methods for treating disease states and conditions which are mediated through GLUT5, including such disease states and conditions as GLUT5 deficiency syndrome, diabetes (type I and II), cancer, metabolic diseases including metabolic syndrome and fatty liver disease, among others.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: November 3, 2020
    Inventors: Tudor I. Oprea, Cristian George Bologa, Oleg Ursu, Jun-Yong Choe, Cristina Iancu
  • HUMAN GLUT5 SPECIFIC INHIBITORS AND METHODS OF TREATMENT
    Publication number: 20180170897
    Abstract: The present invention relates to compounds which have been discovered to be potent ligands (inhibitors) of human GLUT5 (glucose transporter type 5), a facilitative glucose transporter that transports fructose, and their use as ligands assays which can uncover additional ligands of GLUT5, having the potential for being used as drugs. In addition, the present invention is directed to compounds, chemical compositions and methods for treating disease states and conditions which are mediated through GLUT5, including such disease states and conditions as GLUT5 deficiency syndrome, diabetes (type I and II), cancer, metabolic diseases including metabolic syndrome and fatty liver disease, among others.
    Type: Application
    Filed: June 10, 2016
    Publication date: June 21, 2018
    Inventors: Tudor I. Oprea, Cristian George Bologa, Oleg Ursu, Jun-Yong Choe, Cristina Iancu